A new study suggests GLP-1 medications, such as semaglutide, were associated with better overall outcomes in people with type ...

According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist ...

GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations ...

A new oral insulin embedded in sugar-free chocolate uses nano-carriers to target the liver, cutting hypoglycemia risk. The ...

The absolute risk appears low, but new data suggest small changes in smell and taste with GLP-1 treatment may exceed those already associated with type 2 diabetes.

An Australian-first study by the Registry of Senior Australians (ROSA) investigating the use of blood sugar-lowering medications among residents with diabetes in aged care homes nationwide, has ...

Stroke is a leading cause of death and disability worldwide, with staggering statistics that demand urgent attention. Every year, approximately 12.2 million new strokes are diagnosed globally, and one ...

Following the success of obesity treatments, global pharmaceutical and biotech industries are increasingly focusing on the ...

The National Institute for Health and Care Excellence (Nice) has approved teplizumab, which the charity Diabetes UK said ...

Two of the hottest trends in health — longevity medicine and weight loss drugs — are colliding. A theory that GLP-1 ...

Credit: Getty Images Our easy-to-read fact sheets provide patients with an overview for type 2 diabetes medications that also induce weight loss. Our easy-to-read fact sheets provide clinicians with ...